Search results :

Ambrisentan

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: C02KX02

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6
Oedema peripheral Oedema peripheral 17.2% - 28.4% 10.6% x x x x x x
Headache Headache very common, 14.6% - 19.4% 13.6% x x x x x
Sinus headache Sinus headache very common x x x
Migraine Migraine very common x x x
Dizziness Dizziness postmarketing, 6.92% - 8.96% 9.85% x x x x x
Syncope x
Cough Cough 5.38% - 7.46% 6.06% x x x
Upper respiratory tract infection Upper respiratory tract infection 4.62% - 7.46% 6.06% x x x
Nasal congestion Nasal congestion common, 5.38% - 10.4% 1.52% x x x x x x
Dyspnoea Dyspnoea exacerbated 1.49% - 7.69% 6.06% x x x
Dyspnoea postmarketing, 4.21% - 5.38% 3.03% x x x x x
Asthenia Fatigue postmarketing, 4.48% - 5.38% 4.55% x x x x
Asthenia postmarketing x x x x
Fatigue Fatigue postmarketing, 4.48% - 5.38% 4.55% x x x x
Palpitations Palpitations common, 3.85% - 4.6% 2.27% x x x x x
Nausea Nausea postmarketing, 3.85% - 4.48% 9.09% x x x x x
Constipation Constipation common, 3.08% - 5.97% 1.52% x x x x x
Flushing Flushing common, 1.49% - 3.85% 0.758% x x x x x x
Epistaxis Epistaxis 1.54% - 5.97% 3.79% x x x
Nasopharyngitis Nasopharyngitis common, 2.99% - 5.38% 0.758% x x x x x
Sinusitis Sinusitis common, 3.07% - 4.48% 0% x x x x x x
Abdominal pain Abdominal pain common, 2.99% - 3.08% 0.758% x x x x x
Gastrointestinal pain Abdominal pain common, 2.99% - 3.08% 0.758% x x x x x
Bronchitis Bronchitis 1.49% - 4.62% 3.79% x x
Chest pain Chest pain 1.49% - 4.62% 2.27% x x x x
Chest discomfort x
Right ventricular failure Right ventricular failure 1.49% - 4.62% 12.1% x x x
Aspartate aminotransferase increased Aspartate aminotransferase increased 1.54% - 2.99% 3.79% x x
Insomnia Insomnia 1.49% - 2.31% 3.03% x x x
Arthralgia Arthralgia 0.769% - 2.99% 3.79% x x x
Musculoskeletal discomfort Arthralgia 0.769% - 2.99% 3.79% x x x
Myalgia x
Urinary tract infection Urinary tract infection 1.49% - 1.54% 6.06% x x
Pulmonary hypertension Pulmonary hypertension 0.769% - 1.49% 5.3% x x x x
Dermatitis Rash postmarketing, uncommon x x x x x
Rash Rash postmarketing, uncommon x x x x x
Hypersensitivity Hypersensitivity postmarketing, uncommon x x x x x
Anaemia Anaemia postmarketing x x x x x
Angioedema Angioedema postmarketing x x x
Gastrointestinal disorder Gastrointestinal disorder postmarketing x x x x
Cardiac disorder Cardiac disorder postmarketing x x x x
Cardiac failure Cardiac failure postmarketing x x x x
Hepatitis Hepatitis postmarketing x
Mediastinal disorder Mediastinal disorder postmarketing x x x x
Nervous system disorder Nervous system disorder postmarketing x x x
Vomiting Vomiting postmarketing x x x x
Hepatic failure Hepatic failure postmarketing x
Liver injury Liver injury postmarketing x x x x
Traumatic liver injury Liver injury postmarketing x x x x
Hepatotoxicity Hepatotoxicity postmarketing x
Autoimmune hepatitis Autoimmune hepatitis postmarketing x x x
Hepatobiliary disease Hepatobiliary disease postmarketing x x x
Hepatic congestion Hepatic congestion postmarketing x
Fluid retention Fluid retention postmarketing x x x x x x
Transaminases increased Transaminases increased postmarketing x x x
Angina pectoris Angina pectoris x
Decreased appetite Anorexia x
Mental disorder Mental disorder x
Breast disorder Breast disorder x
Infection Infection x
Contusion Contusion x
Diarrhoea Diarrhoea x x
Oedema Oedema x
Body temperature increased Body temperature increased x
Gastritis Gastritis x
Blood disorder Blood disorder x
Haemorrhage Haemorrhage x
Haemoglobin Haemorrhage x
Hypokalaemia Hypokalaemia x
Hypotension Hypotension x
Immune system disorder Immune system disorder x x x x
Influenza Influenza x
Muscle spasms Cramp muscle x
Nocturia Nocturia x
Pharyngitis Pharyngitis x
Pleural effusion Pleural effusion x
Pneumonia Pneumonia x
Pruritus Pruritus x x
Pulmonary oedema Pulmonary oedema x
Pulmonary veno-occlusive disease Pulmonary veno-occlusive disease x
Rales Rales x
Rhinitis Rhinitis x x
Skin ulcer Skin ulcer x
Shock Syncope x
Syncope Syncope x
Loss of consciousness Syncope x
Tachycardia Tachycardia x
Urethral disorder Urinary tract disorder x
Urinary tract disorder Urinary tract disorder x
Angiopathy Angiopathy x x x
Wheezing Wheezing x
Haemoglobin decreased Haemoglobin decreased x x x x
Malnutrition Malnutrition x
Myalgia Myalgia x
Abdominal pain upper Abdominal pain upper x
Discomfort Discomfort x
Chest discomfort Chest discomfort x
Non-cardiac chest pain Non-cardiac chest pain x
Haematocrit decreased Haematocrit decreased x x
Infestation Infestation NOS x
Sleep disorder Sleep disorder x
Sperm concentration decreased Sperm count decreased x
Vaginal haemorrhage Vaginal haemorrhage x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

AMBRISENTAN / LETAIRIS

Side effects:12
Source:FDA

AMBRISENTAN

Side effects:23
Source:FDA Structured Product Label

ambrisentan / ambrisentan

Side effects:44
Source:EMA

ambrisentan / VOLIBRIS

Side effects:46
Source:medicines.org.au

VOLIBRIS / Volibris, Tablet

Side effects:46
Source:Medsafe

AMBRISENTAN / VOLIBRIS

Side effects:65
Source:Health Canada

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label